A Pilot Study of Terazosin for Parkinson's Disease

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 24, 2019

Primary Completion Date

June 5, 2020

Study Completion Date

November 18, 2020

Conditions
Parkinson Disease
Interventions
DRUG

Terazosin 5 MG

5 milligrams by mouth daily at bedtime

DRUG

Placebo oral capsule

1 capsule by mouth daily at bedtime

Trial Locations (1)

52242

University of Iowa Hospitals and Clinics, Iowa City

All Listed Sponsors
collaborator

University of Iowa

OTHER

lead

Jordan Schultz

OTHER